Antimicrobial Resistance Diagnostics Market Share and Growth 2034
Characterized by bacteria, viruses, and fungi that have become unresponsive to antimicrobial medications, AMR stands as one of the leading global public health threats. The development of drug resistance in pathogens renders medications ineffective, which may lead to infections capable of causing sepsis and significantly elevating the risk of severe illness, disability, and mortality.
According to SPER market research, ‘Global Antimicrobial Resistance Diagnostics Market Size- By Product Type, By Technology, By Pathogen Type, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Antimicrobial Resistance Diagnostics Market is predicted to reach 8.85 billion by 2034 with a CAGR of 6.56%.
Drivers:
The antimicrobial resistance (AMR) diagnostics market is witnessing notable growth, driven by the increasing incidence of drug-resistant infections and the pressing necessity for swift, accurate detection methods. The progression of molecular diagnostics, including PCR and next-generation sequencing (NGS), is propelling market advancement. Additionally, government initiatives, enhanced funding for AMR research, and rising awareness among healthcare professionals are further fostering market growth.
Download the Detailed Analysis in PDF format, Here
Restraints:
A significant obstacle in the market for antimicrobial resistance diagnostics is the limited number of effective treatment alternatives available once resistance is identified. Although sophisticated AMR diagnostics can rapidly pinpoint resistant pathogens, the scarcity of novel antibiotics greatly hampers treatment options, diminishing the clinical efficacy of these diagnostics. Often, physicians realize that even with early detection of AMR, the lack of effective second or third-line treatments renders the diagnostic results less applicable. Consequently, there is hesitance to invest in rapid AMR testing, particularly in hospital environments where the use of empirical antibiotics is still widespread.
The global market for antimicrobial resistance diagnostics in 2024 was dominated by North America. The region’s growth can be attributed to various factors, including the heightened risk of antimicrobial resistance, supportive governmental initiatives aimed at combating AMR, and the presence of sophisticated healthcare infrastructure. Furthermore, the existence of key market players and their strategic initiatives are anticipated to further propel segment growth in the forthcoming years. Some of the key market players are Bio-Rad Laboratories, BioMerieux, Beckman Coulter, Abbott Laboratories, Accelerated Diagnostics, USA, Alifax, and others.
For More Information, refer to below link: –
Antimicrobial Resistance Diagnostics Market Growth
Related Reports:
Global Bile Duct Cancer Market Growth
Global Carboprost Tromethamine Market Growth
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant — USA
SPER Market Research
enquiries@sperresearch.com
+1–347–460–2899
